| Name | Title | Contact Details |
|---|
Zags is a new breed of software provider delivering on its vision to change the status quo of insurance administration systems through the disruptive application of technology. Zags designs and develops its insurance solutions with the goal of helping carriers face the growing P&L pressures from increasing regulations and little return on assets. Zags understands that with these challenges comes the need for P&C and Life carriers to find a new way of processing that goes beyond claims, billing, and policy administration. Zags is headquartered in New York with offices in Paris, Minneapolis and Tunis.
Terra Technology is one of the leading providers in Software and Internet. It is based in Norwalk, CT. To find more information about Terra Technology, please visit www.terratechnology.com.
Hybrid PayTech World Inc. Develops an Enterprise Ready Mobile Payment Platform for the leading OS's (IOS, Android, BB and Windows 6,7,8). The Corporation's holding, First Equity Strategy LLC, markets itself with the DBA: Hybrid PayTech. International subsidiaries include Hybrid PayTech Asia Inc, Hybrid PayTech Aspac HK Ltd, Vault Acquiring Solutions LLC and Mobi724 Inc. Hybrid PayTech based in Montreal, Canada, is a technology leader in the mobile payment space for EMV (certification level for credit and debit) & MSR (magnetic card reader) credit and debit acceptance. With a global footprint, Hybrid is an enabler of easily-deployable payment systems focusing on authentication, approved security and quick merchant adoption in Fleet, Delivery, Logistics and Retail. The Canadian National Stock Exchange (CNSX) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy. This news release does not constitute a solicitation to buy or sell any securities in the United States.
Discounts on 2 Million hotels, homes and everything in between. Now offering flight bookings! | Over 20 Million reviews | Last minute deals | Safe & secure
The focus of our company is optimization of biopharmaceutical proteins for multiple applications, such as targeted drug delivery, targeted